ARDT
Price
$18.18Alerts
Change
+$0.25 (+1.39%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
2.44B
Intraday BUY SELL Signals
BMGL
Price
$0.68Alerts
Change
-$1.25 (-64.77%)
Updated
Nov 11 closing price
Capitalization
8.37M
Intraday BUY SELL Signals
Interact to see
Advertisement

ARDT vs BMGL

ARDT vs BMGL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ARDT vs. BMGL commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDT is a Buy and BMGL is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ARDT with price predictions
Nov 10, 2026

ARDT in upward trend: price rose above 50-day moving average on October 07, 2026

ARDT moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend. In 15 of 17 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on ARDT as a result. In 38 of 51 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

The Moving Average Convergence Divergence (MACD) for ARDT just turned positive on November 04, 2026. Looking at past instances where ARDT's MACD turned positive, the stock continued to rise in 13 of 18 cases over the following month. The odds of a continued upward trend are 72%.

The 10-day moving average for ARDT crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.

Following a +13.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARDT advanced for three days, in 90 of 123 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

The Aroon Indicator entered an Uptrend today. In 50 of 85 cases where ARDT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARDT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

ARDT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ARDT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.807) is normal, around the industry mean (204.532). P/E Ratio (31.753) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.238) is also within normal values, averaging (2.688).

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for BMGL with price predictions
Nov 10, 2026

BMGL in upward trend: 10-day moving average crossed above 50-day moving average on October 29, 2026

The 10-day moving average for BMGL crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for BMGL's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

Following a +4.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMGL advanced for three days, in 52 of 64 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

BMGL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 10 of 13 cases where BMGL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 9 of 11 cases where BMGL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMGL as a result. In 40 of 42 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for BMGL turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 19 similar instances when the indicator turned negative. In 17 of the 19 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.

BMGL moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.118) is normal, around the industry mean (204.532). P/E Ratio (-0.773) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.597) is also within normal values, averaging (2.688).

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. BMGL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMGL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
ARDTBMGL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
73%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
77%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (ARDT: $17.93 vs. BMGL: $1.93)
Brand notoriety: ARDT and BMGL are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ARDT: 122% vs. BMGL: 778%
Market capitalization -- ARDT: $2.44B vs. BMGL: $8.37M
ARDT [@Hospital/Nursing Management] is valued at $2.44B. BMGL’s [@Hospital/Nursing Management] market capitalization is $8.37M. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $107.17B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDT’s FA Score shows that 1 FA rating(s) are green while BMGL’s FA Score has 1 green FA rating(s).

  • ARDT’s FA Score: 1 green, 4 red.
  • BMGL’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARDT and BMGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDT’s TA Score shows that 6 TA indicator(s) are bullish while BMGL’s TA Score has 5 bullish TA indicator(s).

  • ARDT’s TA Score: 6 bullish, 4 bearish.
  • BMGL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ARDT is a better buy in the short-term than BMGL.

Price Growth

ARDT (@Hospital/Nursing Management) experienced а +53.12% price change this week, while BMGL (@Hospital/Nursing Management) price change was -62.96% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -5.65%. For the same industry, the average monthly price growth was +0.49%, and the average quarterly price growth was +11.07%.

Industries' Descriptions

@Hospital/Nursing Management (-5.65% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ARDT and

Correlation & Price change

A.I.dvisor tells us that ARDT and HCA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARDT and HCA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDT
1D Price
Change %
ARDT100%
-0.22%
HCA - ARDT
32%
Poorly correlated
-0.09%
ADUS - ARDT
30%
Poorly correlated
+3.16%
UHS - ARDT
30%
Poorly correlated
-0.89%
PNTG - ARDT
28%
Poorly correlated
+1.32%
THC - ARDT
27%
Poorly correlated
+0.44%
More

BMGL and

Correlation & Price change

A.I.dvisor tells us that BMGL and ARDT have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMGL and ARDT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMGL
1D Price
Change %
BMGL100%
-64.26%
ARDT - BMGL
12%
Poorly correlated
-0.22%
ASTH - BMGL
7%
Poorly correlated
-4.71%
PACS - BMGL
5%
Poorly correlated
+0.68%
AUNA - BMGL
4%
Poorly correlated
-2.34%
GRDN - BMGL
3%
Poorly correlated
+6.02%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPET1.640.04
+2.50%
Trio Petroleum Corp.
EPM3.570.03
+0.85%
Evolution Petroleum Corp
OII35.060.21
+0.60%
Oceaneering International
OMC88.840.34
+0.38%
Omnicom Group
PSTL22.71-0.23
-1.00%
Postal Realty Trust